February 18, 2021
Skye is limitless
Unlocking the pharmaceutical potential of cannabinoids
We are a biopharmaceutical company engineering proprietary cannabinoid derivatives to treat glaucoma and other diseases with significant unmet medical needs
Our innovative approach to drug development enables us to transform cannabinoids into safer, more effective pharmaceutical agents. By advancing our novel drugs, we are working to bring important new medicines to market by unlocking the potential of cannabinoids.